Selected Presentations Impact of Managed Care on Pharmacy Practice and Education
نویسنده
چکیده
INTRODUCTION The American health care system is in a period of historic change that is certain to impact all health care professions and provider organizations. These changes are the result of the rapid transition from a delivery system based on indemnity insurance that pays submitted charges to individual physicians, pharmacists, and hospitals to one that is founded on capitated contracts with Managed Care Organizations (MCOs). The MCOs often pass the risk on to local hospital and physician run delivery systems.
منابع مشابه
Assessment of knowledge and quality of practice of proper foot care in Iranian patients with type 2 diabetes
Background: Uncontrolled diabetes can lead to a high rate of complications. Diabetic foot ulcer (DFU), leading to significant morbidity. However, DFU can be prevented and managed through education of patient foot care. Objectives: The current study aimed to evaluate the knowledge and practice routines of patients with type 2 diabetes (T2DM) regarding foot care. Methods: A questionnaire was de...
متن کاملPharmacist work force in 2020: implications of requiring residency training for practice.
Copyright © 2008, American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/08/0102-0166$06.00. DOI 10.2146/ajhp070231 Pharmacy is undergoing a transformation from a profession of primarily providing a commodity (medications) in reaction to the orders of a prescriber to one of providing and ensuring optimal drug therapy in conjunction with a prescriber and other members...
متن کاملTargeted therapies in the treatment of colorectal cancer: what managed care needs to know.
OBJECTIVE This review is designed to explore the disease, its current treatment, the expanding field of antiangiogenic treatments, and the implications of these advances for the managed care patient. DATA SOURCES This article is based, in part, on presentations given by the authors in a continuing education symposium presented during the Academy of Managed Care Pharmacy.s 16th Annual Meeting ...
متن کاملAMCP Partnership Forum: Driving New Advances in Dyslipidemia Management.
UNLABELLED Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors are specialty medications approved for the treatment of dyslipidemia. Because dyslipidemia is a prevalent and chronic condition, the costs associated with PCSK9 inhibitors must be carefully weighed against the benefits that they provide. However, the long-term clinical benefits of these agents are not yet fully defined, crea...
متن کاملIncorporating the treat-to-target concept in rheumatoid arthritis.
BACKGROUND Recent publications have proposed revisions to disease classification criteria, new definitions of remission, and guidelines for implementing treat-to-target strategies for the management of patients with rheumatoid arthritis (RA). Despite developments leading to this practice-changing approach, the concept of treat to target has not yet been widely accepted or implemented in managed...
متن کامل